Mind Body Matrix Pain Relief

Description

The product is identified by the SPL code 34089-3. No additional specific description details are available.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of the muscles and joints associated with conditions such as arthritis, simple backache, sprains, bruises, and strains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged two years and older, the recommended application is to apply the medication to the affected area no more than three to four times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under two years of age, it is advised to consult a physician prior to use. This ensures that appropriate guidance is provided based on the individual needs of the child.

Contraindications

The product is contraindicated for application to wounds or damaged skin due to the potential for irritation or adverse reactions. Additionally, it should not be used with tight bandaging, as this may compromise circulation and lead to further complications.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid contact with the eyes to prevent irritation or injury. In cases where symptoms persist for more than seven days, it is recommended that patients discontinue use and consult a physician for further evaluation.

In the event of accidental ingestion, patients should seek medical advice promptly. It is crucial to instruct patients not to apply the product to wounds or damaged skin, as this may exacerbate the condition or lead to adverse effects. Additionally, patients should be cautioned against tightly bandaging the area of application, as this may increase the risk of localized reactions.

For patients who are pregnant or breastfeeding, it is essential to recommend contacting a physician prior to use to ensure safety for both the mother and child.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only, and contact with the eyes should be avoided. In the event that symptoms persist for more than seven days, patients are advised to discontinue use and consult a physician.

It is crucial to keep the product out of reach of children. If swallowed, patients should seek medical advice immediately. The product should not be applied to wounds or damaged skin, and it is recommended that it not be bandaged tightly.

For pregnant or breastfeeding individuals, it is essential to contact a physician prior to use to ensure safety and appropriateness of the product.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Mind Body Matrix Pain Relief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under two years of age should consult a physician prior to use. For adults and children aged two years and older, the recommended application is to the affected area not more than three to four times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients are advised to contact their physician prior to the use of this medication. The potential risks and benefits should be carefully considered, as the effects on fetal outcomes are not fully established. It is essential for healthcare providers to evaluate the individual circumstances of pregnant patients to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to contact their physician prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If the product is ingested, the first step is to consult a physician for further evaluation and management.

Potential symptoms of overdosage may vary depending on the specific circumstances and the individual’s health status. Therefore, close monitoring of the patient is essential to identify any adverse effects that may arise.

Management of overdosage should be guided by the physician's recommendations, which may include supportive care and symptomatic treatment as necessary. It is crucial to follow established protocols for the management of overdosage to ensure patient safety and optimal outcomes.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to contact a physician prior to use. No specific non-teratogenic effects have been identified. Additionally, there are no detailed findings related to nonclinical toxicology or animal pharmacology and toxicology available.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to consult a physician immediately if the product is swallowed. It is important to emphasize that the product should not be applied to wounds or damaged skin, as this may lead to adverse effects. Additionally, patients should be instructed not to bandage the area tightly after application, as this could interfere with the product's effectiveness and safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged two years or older being three to four times daily to the affected area. For children under two years of age, it is advised to consult a physician prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mind Body Matrix Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)